Regulación del desarrollo post-embrionario de la raíz de Arabidopsis thaliana por N-acil-L-homoserina lactonas, una clase de compuestos moduladores de la proliferación celular en bacterias.

Las plantas para modular su crecimiento y desarrollo dependen de diferentes tipos de substancias conocidas comúnmente como reguladores del crecimiento vegetal o fitohormonas, entre los que destacan las auxinas, las citocininas, el etileno, las giberelinas y el ácido abscísico. Recientemente ha sido descrita una clase novedosa de compuestos lipídicos que incluye a las alcamidas y las N-aciletanolamidas. Estos compuestos pueden ser acumulados en los diferentes tejidos de la planta o secretados por la raíz modificando las características de su entorno rizosférico. En las bacterias, también se han encontrado moléculas de estructura química similar a las alcamidas, las N-acil homoserina lactonas, que regulan diferentes procesos celulares dependientes de su densidad poblacional, mediante el mecanismo de señalización conocido como quorum-sensing. Aunque las N-acil homoserina lactonas (AHLs) se han estudiado con gran detalle por su importancia en la comunicación célula-célula entre las bacterias Gram negativas, poco se conoce acerca de la respuesta de las plantas a estos compuestos. En este trabajo se caracterizaron los efectos de diferentes AHLs sobre el desarrollo post-embrionario de la raíz de Arabidopsis thaliana para determinar su actividad en las plantas. Se observaron diferentes efectos de las AHLs dependiendo de la longitud de su cadena de ácido graso, incluyendo la inhibición en el crecimiento de la raíz primaria y la estimulación en la formación de raíces laterales y pelos radiculares. Las AHLs con longitud de cadena de ácido graso de 8 a 12 carbonos fueron las que mostraron una mayor actividad biológica y en particular, la N-decanoil-HL fue el compuesto con efectos más notorios sobre el desarrollo de la raíz. Para evaluar los efectos de la N-decanoil-HL sobre los procesos de división celular y diferenciación se analizaron los cambios en la expresión de los marcadores del ciclo celular CyCB1:uidA y PRZ1:uidA y de diferenciación AtEXP7:uidA

Phytochrome and flowering time1/mediator25: regulates lateral root formation via auxin signaling in arabidopsis

Root system architecture is a major determinant of water and nutrient acquisition as well as stress tolerance in plants. The Mediator complex is a conserved multiprotein complex that acts as a universal adaptor between transcription factors and the RNA polymerase II. In this article, we characterize possible roles of theMEDIATOR8 (MED8) and MED25 subunits of the plant Mediator complex in the regulation of root system architecture in Arabidopsis (Arabidopsis thaliana). We found that loss-of-functionmutations in PHYTOCHROME AND FLOWERING TIME1 (PFT1)/MED25 increase primary and lateral root growth as well as lateral and adventitious root formation. In contrast, PFT1/MED25 overexpression reduces these responses, suggesting that PFT1/MED25 is an important element of meristematic cell proliferation and cell size control in both lateral and primary roots. PFT1/MED25 negatively regulates auxin transport and response gene expression in most parts of the plant, as evidenced by increased and decreased expression of the auxin-related reporters PIN-FORMED1 (PIN1)::PIN1::GFP (for green fluorescent protein), DR5:GFP, DR5:uidA, and BA3:uidA in pft1-2 mutants and in 35S:PFT1 seedlings, respectively. No alterations in endogenous auxin levels could be found in pft1-2 mutants or in 35S:PFT1-overexpressing seedlings. However, detailed analyses of DR5:GFP and DR5:uidA activity in wildtype, pft1-2, and 35S:PFT1 seedlings in response to indole-3-acetic acid, naphthaleneacetic acid, and the polar auxin transport inhibitor 1-N-naphthylphthalamic acid indicated that PFT1/MED25 principally regulates auxin transport and response. These results provide compelling evidence for a new role for PFT1/MED25 as an important transcriptional regulator of root system architecture through auxin-related mechanisms in Arabidopsis

Characterization of plant growth-promoting bacteria associated with avocado trees (Persea americana Miller) and their potential use in the biocontrol of Scirtothrips perseae (avocado thrips).

Plants interact with a great variety of microorganisms that inhabit the rhizosphere or the epiphytic and endophytic phyllosphere and that play critical roles in plant growth as well as the biocontrol of phytopathogens and insect pests. Avocado fruit damage caused by the thrips species Scirtothrips perseae leads to economic losses of 12-51% in many countries. In this study, a screening of bacteria associated with the rhizosphere or endophytic phyllosphere of avocado roots was performed to identify bacterial isolates with plant growth-promoting activity in vitro assays with Arabidopsis seedlings and to assess the biocontrol activity of the isolates against Scirtothrips perseae. The isolates with beneficial, pathogenic and/or neutral effects on Arabidopsis seedlings were identified. The plant growth-promoting bacteria were clustered in two different groups (G1 and G3B) based on their effects on root architecture and auxin responses, particularly bacteria of the Pseudomonas genus (MRf4-2, MRf4-4 and TRf2-7) and one Serratia sp. (TS3-6). Twenty strains were selected based on their plant growth promotion characteristics to evaluate their potential as thrips biocontrol agents. Analyzing the biocontrol activity of S. perseae, it was identified that Chryseobacterium sp. shows an entomopathogenic effect on avocado thrips survival. Through the metabolic profiling of compounds produced by bacteria with plant growth promotion activity, bioactive cyclodipeptides (CDPs) that could be responsible for the plant growth-promoting activity in Arabidopsis were identified in Pseudomonas, Serratia and Stenotrophomonas. This study unravels the diversity of bacteria from the avocado rhizosphere and highlights the potential of a unique isolate to achieve the biocontrol of S. perseae

Physical properties of Hi'iaka from stellar occultation data

Two very bright stellar occultations by Hi'iaka, the largest satellite of the dwarf planet Haumea, were predicted to take place during in April 2021. Since the uncertainty on Hi'iaka's shadow path was large due to uncertainty on Hi'iaka's position with respect to Haumea, we performed an observational campaign using medium-sized telescopes to obtain high accuracy astrometric data of Hi'iaka's orbit around Haumea. The astrometric data allowed us to successfully observe the first stellar occultation on April 6[SUP]th[/SUP], with final path crossing North Africa. We only obtained one positive chord in this event from the TRAPPIST-North telescope at Oukaïmeden Observatory (Morocco), but thanks to this detection, we were able to obtain a more accurate path for the second event on April 16[SUP]th[/SUP]. The second shadow path was predicted to cross the continental US from East to West. We carried out a huge observational campaign involving more than 50 professional and amateur observatories across the US and southern Canada. The final path of this second stellar occultation moved slightly to the North of the predicted path and, as a result, we were able to obtain 5 positive chords and negative chords only from the south of the shadow. We also collected photometric data in order to obtain Hi'iaka's rotational light-curve and calculate its three-dimensional shape. The rotational light-curve was obtained by observing the unresolved system of Haumea-Hi'iaka and removing Haumea's rotational light-curve from the data. Using Hi'iaka's rotational light-curve we obtained the rotational phase at which each stellar occultation took place, which allowed us to obtain a three-dimensional model of the satellite. Preliminary results from the stellar occultation show that Hi'iaka, with a triaxial shape as suggested in previous publications, is larger than what has been thought before and with a similar albedo to that of Haumea. In this talk we will present our analysis and preliminary results of some of Hi'iaka's physical properties

Libro de Proyectos Finales 2021 primer semestre

PregradoIngeniero CivilIngeniero de SistemasIngeniero ElectricistaIngeniero ElectrónicoIngeniero IndustrialIngeniero Mecánic

Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study.

Background: Small, randomized trials of cervical artery dissection (CAD) patients showed conflicting results regarding optimal stroke prevention strategies. We aimed to compare outcomes in patients with CAD treated with antiplatelets versus anticoagulation. Methods: This is a multi-center observational retrospective international study (16 countries, 63 sites) that included CAD patients without major trauma. The exposure was antithrombotic treatment type (anticoagulation vs. antiplatelets) and outcomes were subsequent ischemic stroke and major hemorrhage (intracranial or extracranial hemorrhage). We used adjusted Cox regression with Inverse Probability of Treatment Weighting (IPTW) to determine associations between anticoagulation and study outcomes within 30 and 180 days. The main analysis used an "as treated" cross-over approach and only included outcomes occurring on the above treatments. Results: The study included 3,636 patients [402 (11.1%) received exclusively anticoagulation and 2,453 (67.5%) received exclusively antiplatelets]. By day 180, there were 162 new ischemic strokes (4.4%) and 28 major hemorrhages (0.8%); 87.0% of ischemic strokes occurred by day 30. In adjusted Cox regression with IPTW, compared to antiplatelet therapy, anticoagulation was associated with a non-significantly lower risk of subsequent ischemic stroke by day 30 (adjusted HR 0.71 95% CI 0.45-1.12, p=0.145) and by day 180 (adjusted HR 0.80 95% CI 0.28-2.24, p=0.670). Anticoagulation therapy was not associated with a higher risk of major hemorrhage by day 30 (adjusted HR 1.39 95% CI 0.35-5.45, p=0.637) but was by day 180 (adjusted HR 5.56 95% CI 1.53-20.13, p=0.009). In interaction analyses, patients with occlusive dissection had significantly lower ischemic stroke risk with anticoagulation (adjusted HR 0.40 95% CI 0.18-0.88) (Pinteraction=0.009). Conclusions: Our study does not rule out a benefit of anticoagulation in reducing ischemic stroke risk, particularly in patients with occlusive dissection. If anticoagulation is chosen, it seems reasonable to switch to antiplatelet therapy before 180 days to lower the risk of major bleeding. Large prospective studies are needed to validate our findings

A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial

Background Timing of initiation of kidney-replacement therapy (KRT) in critically ill patients remains controversial. The Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial compared two strategies of KRT initiation (accelerated versus standard) in critically ill patients with acute kidney injury and found neutral results for 90-day all-cause mortality. Probabilistic exploration of the trial endpoints may enable greater understanding of the trial findings. We aimed to perform a reanalysis using a Bayesian framework. Methods We performed a secondary analysis of all 2927 patients randomized in multi-national STARRT-AKI trial, performed at 168 centers in 15 countries. The primary endpoint, 90-day all-cause mortality, was evaluated using hierarchical Bayesian logistic regression. A spectrum of priors includes optimistic, neutral, and pessimistic priors, along with priors informed from earlier clinical trials. Secondary endpoints (KRT-free days and hospital-free days) were assessed using zero–one inflated beta regression. Results The posterior probability of benefit comparing an accelerated versus a standard KRT initiation strategy for the primary endpoint suggested no important difference, regardless of the prior used (absolute difference of 0.13% [95% credible interval [CrI] − 3.30%; 3.40%], − 0.39% [95% CrI − 3.46%; 3.00%], and 0.64% [95% CrI − 2.53%; 3.88%] for neutral, optimistic, and pessimistic priors, respectively). There was a very low probability that the effect size was equal or larger than a consensus-defined minimal clinically important difference. Patients allocated to the accelerated strategy had a lower number of KRT-free days (median absolute difference of − 3.55 days [95% CrI − 6.38; − 0.48]), with a probability that the accelerated strategy was associated with more KRT-free days of 0.008. Hospital-free days were similar between strategies, with the accelerated strategy having a median absolute difference of 0.48 more hospital-free days (95% CrI − 1.87; 2.72) compared with the standard strategy and the probability that the accelerated strategy had more hospital-free days was 0.66. Conclusions In a Bayesian reanalysis of the STARRT-AKI trial, we found very low probability that an accelerated strategy has clinically important benefits compared with the standard strategy. Patients receiving the accelerated strategy probably have fewer days alive and KRT-free. These findings do not support the adoption of an accelerated strategy of KRT initiation